---
title: "SIGMA PHARMACEUTICALS PLC — Ownership Dossier"
canonical: https://whiteintel.dev/entity/7d82e338-05cb-502d-9424-cdfe8ad05401
json: https://whiteintel.dev/api/public/dossier/7d82e338-05cb-502d-9424-cdfe8ad05401
identifier: oo:GB-COH-01561802
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SIGMA PHARMACEUTICALS PLC

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-01561802`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/7d82e338-05cb-502d-9424-cdfe8ad05401  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/7d82e338-05cb-502d-9424-cdfe8ad05401  

## Cross-source identity

The same real-world entity, resolved across sources:

- **SIGMA PHARMACEUTICALS PLC** — GLEIF · `lei:549300QSDOOY04YQ0O18` — https://whiteintel.dev/entity/6386fcb5-8d15-5f1c-9e8a-37b59f9074fe

## Ownership & control

### Owners / controllers

- **ORION HOLDINGS (UK) LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/9c3dcd56-6044-5dc3-a44a-06986fc9b760
- **ORION HOLDINGS (UK) LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/9c3dcd56-6044-5dc3-a44a-06986fc9b760

### Holdings / subsidiaries

- **SPECIAL CONCEPT DEVELOPMENT (UK) LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/45abe418-e687-5086-ba56-f04bdff6082c
- **RX FARMA LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/aeb2b160-a9e6-5461-a5f2-a72dee037a1a
- **SELECTIVE SUPPLIES LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/3bad8704-9e18-5006-a38d-c3155312a9dd
- **OPD LABORATORIES LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/dc044472-a82c-5053-b732-307a499e034c
- **SELECTIVE SUPPLIES LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/3bad8704-9e18-5006-a38d-c3155312a9dd
- **OPD LABORATORIES LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/dc044472-a82c-5053-b732-307a499e034c
- **SPECIAL CONCEPT DEVELOPMENT (UK) LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/45abe418-e687-5086-ba56-f04bdff6082c
- **RX FARMA LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/aeb2b160-a9e6-5461-a5f2-a72dee037a1a

### UBO chain (walk to the ultimate owner)

A **3-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `01561802`
- **Status:** active
- **Type:** plc
- **Incorporated:** 1981-05-15
- **Registered office:** Fifth Floor Watson House, 54-60 Baker Street, London, W1U 7BU, United Kingdom
- **SIC:** 46460

### Officers

- SHAH, Bhavin Manish — secretary · appointed 2021-01-05
- HAMPTON, Mark Richard — director · British · appointed 2022-07-01
- HARIA, Rajesh Shantilal — director · British · appointed 2020-04-21
- SHAH, Bhavin Manish — director · British · appointed 2011-03-04
- SHAH, Hatul Bharat Kumar — director · British · appointed 2011-03-04
- SHAH, Rajiv Bharat Kumar — director · British · appointed 2011-03-04
- SHAH, Bharat Kumar — secretary · Kenyan · resigned 1994-03-02
- SHAH, Kamal Hansraj — secretary · British · appointed 1994-03-02 · resigned 2004-03-10
- SHAH, Manish Hansraj — secretary · British · appointed 2004-03-10 · resigned 2021-01-05
- MOIR, James Marcus  Henry — director · British · appointed 2022-04-14 · resigned 2026-09-01
- PATEL, Pravesh — director · British · appointed 2020-04-21 · resigned 2021-07-26
- SHAH, Bharat Kumar Hansraj Devraj — director · British · resigned 2020-12-22
- SHAH, Divya Kamal — director · British · appointed 1995-03-01 · resigned 2009-03-15
- SHAH, Hansraj Devraj — director · British · appointed 2001-04-02 · resigned 2015-04-26
- SHAH, Jayoti Bharat — director · British · appointed 1995-03-01 · resigned 2020-04-21
- SHAH, Kalpana Manish — director · British · appointed 1995-03-01 · resigned 2020-04-21
- SHAH, Kamal Hansraj — director · British · resigned 2020-12-22
- SHAH, Manish Hansraj — director · British · resigned 2020-12-22
- SHAH, Nishal Kumar, Dr — director · British · appointed 2016-02-10 · resigned 2020-04-21
- SHAH, Paras Kamal — director · British · appointed 2014-11-12 · resigned 2025-05-06

### Beneficial owners (Persons with Significant Control)

- [Orion Holdings (Uk) Limited](https://whiteintel.dev/entity/9c3dcd56-6044-5dc3-a44a-06986fc9b760) — 75–100% shares · corporate PSC · United Kingdom — since 2016-04-06

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/01561802
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/01561802

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **SIGMA PHARMACEUTICALS PLC** — https://whiteintel.dev/entity/7d82e338-05cb-502d-9424-cdfe8ad05401 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SIGMA PHARMACEUTICALS PLC**. Human view: https://whiteintel.dev/entity/7d82e338-05cb-502d-9424-cdfe8ad05401 · Structured JSON: https://whiteintel.dev/api/public/dossier/7d82e338-05cb-502d-9424-cdfe8ad05401._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._